Abstract
Purpose
This retrospective study aims to evaluate the efficacy and safety of salvage HDR brachytherapy in second local recurrences of prostate cancer after applying radical prostatectomy (RP) and post-operative external beam radiotherapy (EBRT).
Materials and methodology
Fifteen patients with locally recurrent prostate cancer after RP and EBRT were salvaged with HDR brachytherapy. Patients had no nodal or distant metastasis evidence on imaging findings, including whole body bone scan, CT scan, and MRI or PSMA PET scan. HDR brachytherapy was applied with 36 Gy in four fractions, in two implantations with 1 week apart. We followed the patients for a control visit every 3 months for 2 years, and every 6 months thereafter.
Results
Fifteen patients with the mean age of 64 years (ranged 51–79) underwent salvage HDR brachytherapy. The mean baseline level of PSA was calculated 2.26 ng/ml (ranged from 0.21 to 9, SD = 2.33), which has been significantly decreased in all patients. Hence, two of our patients experienced a biochemical failure during the follow-up period. Our results showed that 86.6% (n = 13) of patients had never experienced a significant increment in PSA level after a median follow-up of 48 months (ranging from 12 to 132 months). Besides, salvage HDR brachytherapy did not induce any significant side effects such as acute or late rectal complications, despite causing urinary complication.
Conclusions
HDR brachytherapy could be considered as a treatment in well-selected patients with the second recurrence in their prostatic bed after the former EBRT allowing for dose escalating to the second nodular recurrence.
Similar content being viewed by others
References
Hamdy FC, Donovan JL, Lane JA et al (2016) 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415–1424. https://doi.org/10.1056/NEJMOA1606220
Boorjian SA, Thompson RH, Siddiqui S et al (2007) Long-Term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178:864–871. https://doi.org/10.1016/j.juro.2007.05.048
Bianco FJ, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66:83–94. https://doi.org/10.1016/j.urology.2005.06.116
Chun FK-H, Graefen M, Zacharias M et al (2006) Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006(24):273–280. https://doi.org/10.1007/S00345-006-0058-2
Han M, Partin AW, Pound CR et al (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin N Am 28:555–565. https://doi.org/10.1016/S0094-0143(05)70163-4
Pisansky TM, Thompson IM, Valicenti RK et al (2019) Adjuvant and salvage radiotherapy after prostatectomy: astro/aua guideline amendment 2018–2019. J Urol 202:533–538. https://doi.org/10.1097/JU.0000000000000295
Yamada Y, Kollmeier MA, Pei X et al (2014) A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 13:111–116. https://doi.org/10.1016/j.brachy.2013.11.005
Hennequin C, Hannoun-Lévi JM, Rozet F (2017) Management of local relapse after prostate cancer radiotherapy: surgery or radiotherapy? Cancer/Radiothérapie 21:433–436. https://doi.org/10.1016/J.CANRAD.2017.07.026
Chen CP, Weinberg V, Shinohara K et al (2013) Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys 86:324–329. https://doi.org/10.1016/j.ijrobp.2013.01.027
Thiruthaneeswaran N, Hoskin PJ (2016) High dose rate brachytherapy for prostate cancer: standard of care and future direction. Cancer/Radiotherapie 20:66–72
Kumar AMS, Smith KL, Reddy CA et al (2015) Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy. J Contemp Brachyther 7:241–246. https://doi.org/10.5114/jcb.2015.54050
Bomers JGR, Overduin CG, Jenniskens SFM et al (2020) Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up. J Vasc Interv Radiol 31:35–41. https://doi.org/10.1016/J.JVIR.2019.07.001
Gelet A, Chapelon JY, Poissonnier L et al (2004) Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63:625–629. https://doi.org/10.1016/J.UROLOGY.2004.01.002
Murat FJ, Poissonnier L, Rabilloud M et al (2009) Mid-term results demonstrate salvage high- intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 55:640–649. https://doi.org/10.1016/J.EURURO.2008.04.091
Gomez-Veiga F, Mariño A, Alvarez L et al (2012) Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy. BJU Int 109:17–21. https://doi.org/10.1111/j.1464-410X.2011.10826.x
Losa A, Nava LD, Di Muzio N et al (2003) Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy. Urology 62:1068–1072. https://doi.org/10.1016/S0090-4295(03)00784-2
Cuccia F, Mazzola R, Nicosia L et al (2020) Prostate re-irradiation: current concerns and future perspectives. Expert Rev Anticancer Ther 20:947–956. https://doi.org/10.1080/14737140.2020.1822742
Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77:1338–1344. https://doi.org/10.1016/j.ijrobp.2009.06.061
Kwok Y, Narang M, Molitoris JK (2019) Salvage prostate brachytherapy after definitive external radiation: tried and now tested. Transl Androl Urol 8:S232. https://doi.org/10.21037/TAU.2019.01.12
Henríquez I, Sancho G, Hervás A et al (2014) Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol 91(9):1–8. https://doi.org/10.1186/1748-717X-9-102
Chiarlone R, Vallerga F, Arboscello C et al (2017) Salvage LDR brachytherapy in local relapse after radical prostatectomy. Brachytherapy 16:S116. https://doi.org/10.1016/J.BRACHY.2017.04.227
Chitmanee P, Tsang Y, Tharmalingam H et al (2020) Single-dose focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clin Oncol 32:259–265. https://doi.org/10.1016/j.clon.2019.10.008
Schönle N, Strnad V, Lotter M et al (2020) Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer. Radiother Oncol 150:201–205. https://doi.org/10.1016/J.RADONC.2020.06.031
Cuccia F, Nicosia L, Mazzola R et al (2020) Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer. Strahlentherapie und Onkol 196:628–636. https://doi.org/10.1007/s00066-020-01628-6
Acknowledgements
The authors are thankful to the patients and hospital staff for their collaboration.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All the authors of this manuscript declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aghili, M., Jafari, F., Yamrali, M. et al. Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy. Int Urol Nephrol 54, 1031–1037 (2022). https://doi.org/10.1007/s11255-022-03155-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03155-y